Perfil
Martin Steiner is the founder of ImVisioN Therapeutics AG, which was founded in 2008.
He held the position of Director, Chief Executive & Financial Officer from 2011 to 2014.
Dr. Steiner is currently the President, Secretary, Treasurer & Director at ImVision Therapeutics, Inc. and Co-Managing Director at SYNIMMUNE GmbH since 2016.
In the past, he was the Chief Executive Officer at Apovia AG from 1997 to 2004 and Director-Business Development at Smithkline Beecham Biologicals Immunotherapeutics in 1997.
Dr. Steiner was also the Chief Executive & Financial Officer at ImVisioN GmbH.
Dr. Steiner holds an MBA from the University of Michigan and a doctorate from the University of Vienna.
Cargos activos de Martin Steiner
| Empresas | Cargo | Inicio |
|---|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | Presidente | - |
SYNIMMUNE GmbH
SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Director Ejecutivo | 01/03/2016 |
Antiguos cargos conocidos de Martin Steiner.
| Empresas | Cargo | Fin |
|---|---|---|
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Director Ejecutivo | 13/02/2014 |
Apovia AG | Presidente | 01/01/2004 |
Smithkline Beecham Biologicals Immunotherapeutics | Corporate Officer/Principal | 01/01/1997 |
ImVisioN GmbH
ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Director Ejecutivo | - |
Formación de Martin Steiner.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImVisioN GmbH
ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Commercial Services |
Apovia AG | |
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Commercial Services |
Smithkline Beecham Biologicals Immunotherapeutics | |
SYNIMMUNE GmbH
SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Commercial Services |
- Bolsa de valores
- Insiders
- Martin Steiner
















